Endothelial dysfunction is defined as impairment of the balance between endothelium-dependent vasodilation and constriction. Despite evidence of
uric acid-induced endothelial dysfunction, a relationship with
insulin resistance has not been clearly established. In this study, we investigated the role of vascular
insulin resistance in
uric acid-induced endothelial dysfunction.
Uric acid inhibited
insulin-induced
endothelial nitric oxide synthase (eNOS) phosphorylation and NO production more substantially than
endothelin-1 expression in HUVECs, with IC50 of 51.0, 73.6, and 184.2, respectively. Suppression of eNOS phosphorylation and NO production by
uric acid was PI3K/Akt-dependent, as verified by the transfection with p110. Treatment of rats with the
uricase inhibitor
allantoxanamide induced mild
hyperuricemia and increased mean arterial pressure by 25%. While hyperuricemic rats did not show systemic
insulin resistance, they showed impaired vasorelaxation induced by
insulin by 56%. A compromised
insulin response in terms of the Akt/eNOS pathway was observed in the aortic ring of hyperuricemic rats. Coadministration with
allopurinol reduced serum
uric acid levels and blood pressure and restored the effect of
insulin on Akt-eNOS pathway and vasorelaxation. Taken together,
uric acid induced endothelial dysfunction by contributing to vascular
insulin resistance in terms of
insulin-induced NO production, potentially leading to the development of
hypertension.-Choi, Y.-J., Yoon, Y., Lee, K.-Y., Hien, T. T., Kang, K. W., Kim, K.-C., Lee, J., Lee, M.-Y., Lee, S. M., Kang, D.-H., Lee, B.-H.
Uric acid induces endothelial dysfunction by vascular
insulin resistance associated with the impairment of
nitric oxide synthesis.